SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-109722
Filing Date
2022-10-18
Accepted
2022-10-18 16:51:01
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2228107d1_s3.htm S-3 314829
2 EXHIBIT 4.6 tm2228107d1_ex4-6.htm EX-4.6 470915
3 EXHIBIT 4.7 tm2228107d1_ex4-7.htm EX-4.7 500510
4 EXHIBIT 5.1 tm2228107d1_ex5-1.htm EX-5.1 44977
5 EXHIBIT 23.2 tm2228107d1_ex23-2.htm EX-23.2 3037
6 EXHIBIT 23.3 tm2228107d1_ex23-3.htm EX-23.3 2191
7 EXHIBIT 107 tm2228107d1_ex107.htm EX-FILING FEES 33140
8 GRAPHIC tm2228107d1_ex5-1img001.jpg GRAPHIC 5528
9 GRAPHIC tm2228107d1_ex5-1img002.jpg GRAPHIC 5913
10 GRAPHIC tm2228107d1_s3img001.jpg GRAPHIC 4822
  Complete submission text file 0001104659-22-109722.txt   1393487
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267933 | Film No.: 221316394
SIC: 2834 Pharmaceutical Preparations